New skin cancer drug NBS20

…uses a patient’s own cancer cells – in essence, turning the cancer against itself. In a way that is unique. Instead of attacking the bulk of cancer cells, NeoStem’s therapy targets a patient’s cancer-initiating cells, often called “cancer stem cells,” which are those that proliferate cancer cells, spreading the disease and forming new tumors throughout the body.

Read more.